Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.
This bill would add a new section to the Public Health Law establishing a uterine fibroids awareness and education program within the Department of Health. The department would be required to conduct an ongoing public awareness campaign focused on the symptoms, diagnosis, and treatment of uterine fibroids, with particular attention to the elevated risk for minority women.
The bill directs the department to produce and distribute educational materials for patients and health care providers, post related information on its website, and periodically review available data so the materials can be updated as needed. It also allows the department to use educational materials produced by other public, private, or governmental entities instead of creating its own.
The bill would also require the department to report every three years, beginning January 1, 2028, to the governor and legislative leaders on implementation and any recommendations for further action. Implementation is contingent on available appropriations, so the program would only operate to the extent funding is provided.
Overall, the bill appears to be a public health outreach measure aimed at improving awareness, earlier diagnosis, and treatment of uterine fibroids, especially among communities identified as at higher risk. Because there are no recorded committee transcripts or votes in the provided material, there is no documented debate or formal legislative sentiment to assess beyond the bill’s stated purpose.
The bill would amend the New York Public Health Law by adding section 267-c and assigning the Department of Health new duties related to uterine fibroids education and outreach. It would not create a direct medical benefit or mandate treatment, but it would require the department to maintain educational content, distribute materials, and report periodically on implementation. The practical impact would fall on the Department of Health, health care providers who receive and distribute the materials, and patients—particularly minority women—who are the target audience for the outreach.
Based on the bill text, the measure is framed as a preventive and educational public health initiative, with an emphasis on addressing disparities affecting minority women. No committee discussion or voting history was provided, so there is no recorded opposition, support, or amendment debate to characterize. The available context suggests a generally positive, health-focused intent rather than a controversial policy change.
The main policy emphasis is on the bill’s focus on minority women, reflecting the stated elevated risk and potential health disparities associated with uterine fibroids. Any practical contention would likely center on implementation details such as funding, the scope of the Department of Health’s outreach obligations, and whether the state should create its own materials or rely on existing public or private educational resources. However, no specific objections or competing viewpoints are documented in the provided materials.